FSVP, Imported Products, and FDA Disease-Claim Classification

Program Guides · Product Classification

FSVP, Imported Products, and FDA Disease-Claim Classification

Published November 19, 2026 · 6 min read

Some imported products are promoted as treating, preventing, mitigating or curing a disease. That language can change how FDA views the product. For importers, FDA disease-claim classification is therefore a question to settle before the Foreign Supplier Verification Program (FSVP) file is built, not after.

Disease-related statements can appear in many places. Examples include packaging, ecommerce pages, blogs, promotional leaflets and inserts shipped with orders. As a result, importers should review the product’s intended use and its documentation before any therapeutic language reaches the U.S. market. Above all, food safety certification and import records should never be treated as permission to make drug claims.

  1. JurisdictionDecide whether the article is a food, a drug or both.
  2. ClaimsInventory labels, websites, inserts and listings.
  3. ScopeCheck FSVP coverage and exemptions.
  4. RolesName the FSVP importer and foreign supplier.
  5. ReassessReview again when claims or formulas change.

Classification comes first; the FSVP pathway follows from it.

Quick answer

FSVP generally applies to food imported or offered for import into the United States, subject to the exemptions and modified requirements in the rule (21 CFR 1.501). Disease claims, however, may change a product’s regulatory classification. Consequently, importers should confirm the product’s FDA status before assuming that standard food FSVP procedures are the right framework.

1. Identify product jurisdiction first

The FSVP rule uses the definition of food in section 201(f) of the Federal Food, Drug, and Cosmetic Act (21 CFR 1.500). The same Act defines a drug to include articles intended for use in the diagnosis, cure, mitigation, treatment or prevention of disease (21 U.S.C. 321(g)(1)). In other words, an article’s intended use can decide which rules apply.

The statute also contains limited carve-outs. For example, a food or dietary supplement is not a drug solely because it carries a health claim made in accordance with the statutory requirements. Because these distinctions are technical, document the formulation, intended use, label claims, website claims and other promotional statements before you choose an import compliance pathway.

2. Understand how FDA reads intended use

FDA’s regulation on intended uses explains that intent is judged objectively (21 CFR 201.128). It may be shown by labeling claims, advertising matter, or oral and written statements by the responsible persons or their representatives. It may also be shown by the circumstances surrounding distribution.

This is why promotional inserts, social posts and online listings matter. A product label may look compliant, while the website tells a different story. Moreover, the regulation notes that a packer, distributor or seller who intends different uses than its source may need labeling for those new uses.

3. Keep FSVP and drug compliance separate

FSVP is a food safety framework. It requires importers of covered food to analyze hazards, evaluate foreign suppliers and verify that hazards are controlled. It does not review or approve marketing claims. Therefore, FSVP documentation or a supplier audit should never be presented as FDA approval of disease-treatment claims or of an unapproved drug.

If a product may be a drug, that question needs its own regulatory assessment. Our related article on why supplier verification is not claims review explores the same boundary for supplements.

Six compliance areas to review

  • Jurisdiction: formulation, intended use and every promotional representation.
  • Separation: FSVP records are not authorization for drug claims.
  • Roles: FSVP importer, foreign supplier, manufacturer and the owners of online and packaging content.
  • Evidence: hazard-analysis and verification records chosen for the actual product, not a generic checklist.
  • Pre-shipment review: packaging, ecommerce descriptions and inserts compared for disease-related uses.
  • Triggers: reassessment when claims, formulation, source, intended use or regulations change.

4. Confirm importer and supplier roles

Where food FSVP applies, identify the FSVP importer. Under 21 CFR 1.500, this is generally the U.S. owner or consignee of the food at entry. If there is none, it is the U.S. agent or representative of the foreign owner or consignee, confirmed in a signed statement of consent. Our guide FSVP 101: Who is your FSVP importer? covers common scenarios.

In addition, name the foreign supplier, the manufacturer and the parties who control online and packaging content. Claims problems often start with whoever writes the product page, not with the factory.

5. Select supplier evidence for the real product

For covered food, choose hazard-analysis and verification records based on the actual product and the legal framework that applies. Avoid a one-size-fits-all supplier checklist. For example, certain dietary supplements and their components follow modified FSVP requirements tied to the dietary supplement CGMP rule (21 CFR 1.511). For a supplement-specific view of scope and disease claims, see imported dietary supplement classification.

6. Review claims before shipment and keep reassessing

Before each launch or relabeling, compare packaging, ecommerce descriptions, promotional inserts and other documents. Look for inconsistent statements or disease-related intended uses. Then record who reviewed the content and what was approved.

Classification is not a one-time decision. Reassess it, together with your supplier-verification decisions, whenever claims, formulation, source, intended use or governing regulations change. Our article on labeling and claims compliance for FSVP describes how claims review fits into a wider compliance program.

FDA disease-claim classification checklist

  • Confirm the product category, intended use and responsible reviewer.
  • Inventory packaging, website content, blogs, product inserts and relevant third-party listings.
  • Flag disease-treatment and disease-prevention statements for regulatory assessment.
  • Confirm FSVP applicability, exemptions or modified requirements for covered food.
  • Maintain current approved wording, reviewer decisions and change history.
  • Document corrective actions and verify that affected materials were updated.

Frequently asked questions

Does FSVP apply to every imported wellness product?

No. Applicability depends on whether the article is food imported or offered for import, and on the exemptions and modified requirements in the FSVP rule. A product that FDA would treat as a drug needs a separate assessment.

Can an importer use FSVP to legalize drug claims?

No. Food supplier verification addresses food safety hazards. It does not authorize the marketing of an unapproved new drug or approve disease-treatment claims.

Why review promotional inserts and websites?

FDA judges intended use objectively. Under 21 CFR 201.128, intent may be shown by labeling claims, advertising matter and statements made by the responsible persons, so materials beyond the label matter.

How Consultare Inc. Group can help

Consultare supports FSVP applicability assessments, importer-role clarification, foreign supplier evaluation where FSVP applies, product-document readiness reviews and records organization. Deliverables and regulatory applicability depend on the agreed engagement scope and the product involved.

Related services

Need help with your FSVP responsibilities?

Discuss your products, documentation, existing review process and next steps with the Consultare team. Request a free consultation to identify potential gaps and plan the next steps.

Request a Free ConsultationBook a Consultation

Start building your compliance system

Prefer to manage compliance yourself? Create a free SystemsBuilder account to organize product and supplier information, approved records, corrective actions and supporting procedures. Software does not replace a product-specific regulatory assessment.

The right time to improve claims governance and supporting records is before an unresolved content gap becomes a regulatory concern.

Primary references

Independent educational content. Consultare Inc. Group is not affiliated with or endorsed by the U.S. Food and Drug Administration (FDA) or any company referenced in the underlying regulatory materials. This article is for general information only and does not constitute regulatory approval, certification or legal advice. Regulatory applicability must be assessed for each product, facility and operation.

Scroll to Top